Test Directory
Browse our comprehensive catalog of genetic tests
Lymphedema, hereditary and other conditions with lymphedema
This panel evaluates genes associated with isolated and syndromic lymphatic malformations (including but not limited to Meige Disease, Lymphedema Tarda and Milroy's Disease and Noonan Syndrome). Genetic diagnosis supports clinical confirmation, subtype classification, and personalized management. Inheritance is typically autosomal dominant with variable expressivity. Somatic mosaicism may underlie some pathogenic variants, necessitating tissue-specific analysis. Family risk assessment is enabled upon identification of causative mutations.
Gene-PanelPorphyrias
Panel testing- Variants in the most frequently analysed porphyria genes
Gene-PanelRASopathy
The RASopathy Gene Panel is a targeted next-generation sequencing (NGS) panel that analyses 25 genes associated with the RAS-MAPK signalling pathway. This pathway plays a critical role in cell growth, differentiation, and development. Germline pathogenic variants in these genes result in a group of clinically overlapping developmental syndromes known as RASopathies. These conditions share common features including craniofacial dysmorphism, congenital heart defects, hypertrophic cardiomyopathy, short stature, intellectual disability, cutaneous abnormalities (e.g., café-au-lait spots, lentigines), and an increased risk of certain malignancies.
Gene-PanelReproductive Carrier Screening; 1. Alpha Thalassaemia; 2. Beta Thalassaemia; 3. Spinal muscular atrophy (SMA); 4. Fragile X syndrome (FXS)
Reproductive Carrier Screening helps identify whether someone carries certain inherited conditions that could affect future children. This panel looks at four important disorders: Alpha thalassemia, Beta thalassemia, Spinal muscular atrophy (SMA), and Fragile X syndrome (FXS). Identifying carrier status provides critical information for individuals and couples planning a family, helping to reduce the risk of passing on severe genetic conditions. It is especially useful for gamete donors, as it ensures donated eggs or sperm are screened for major genetic risks. By providing this information, the test supports safer family planning and healthier outcomes for future generations.
Gene-PanelWhole Exome Sequencing (WES) + mtDNA Seq
Exome sequencing analyzes approximately 20,000 protein-coding genes, including the complete mitochondrial genome, to detect pathogenic single nucleotide variants, small insertions and deletions, and mitochondrial mutations associated with a broad spectrum of genetic disorders. The assay also includes exon-level copy number variant (CNV) detection and evaluation of loss of heterozygosity (LOH), which may indicate uniparental disomy, consanguinity, or chromosomal anomalies. Collectively, these analyses provide a comprehensive genomic assessment to support diagnosis, inform clinical management, and guide familial risk evaluation. The combination of Twist's proprietary double-stranded DNA (dsDNA) probes with optimized library preparation and capture reagents delivers industry-leading uniformity of coverage and the lowest duplicate rates, enabling the generation of high-quality sequencing data. The Twist Comprehensive Exome panel targets 36.8 Mb of human protein-coding regions, covering over 99% of the RefSeq, CCDS, and GENCODE databases. ACMG73 100%; CCDS 100%; CliVar 100%; GenCode v35 99%; RefSeq 100%.
Gene-PanelWhole Mitochondrial Genome Sequencing
Whole mitochondrial genome, single gene(s), common pathogenic variants, large-scale mtDNA rearrangements, including mtDNA NGS. Determination of level of heteroplasmy. Index case and familial/predictive testing.
Gene-Panel